Riskpilot← Back to searchSign inGet full accessAlvolab AB
ABActiveOrg 5594513482Sockenvägen 402Research and experimental development on natural sciences and engineering · NACE 7210Est. 20231-4 employees
Revenue 2025
SEK 0
EBITDA margin
—
-297% vs 2024
Equity ratio
62.8%
Financial strength
Net profit 2025
SEK -68K
-297% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -68K | -297% |
| Net profit | SEK -68K | -297% |
| Total assets | SEK 104K | +216% |
| Equity | SEK 65K | +98% |
| Employees | — | — |
Legal name
Alvolab AB
Org number
5594513482
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9 oktober 2023
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva preklinisk uppdragsforskning inom läkemedelsutveckling.
Address
Sockenvägen 402
Email
startup@wint.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −17 | −68 |
| Depreciation & amort. | — | — |
| EBIT | −17 | −68 |
| Net financials | 0 | 0 |
| Profit before tax | −17 | −68 |
| Tax | — | — |
| Net profit | −17 | −68 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 33 | 104 |
| Equity | 33 | 65 |
| Long-term debt | — | — |
| Short-term debt | — | 39 |
| Total debt | — | 39 |
EBITDA margin
-6757800.0%
This company
15.8%
Market median
-42770986% vs market
20242025
Equity ratio
62.8%
This company
38.2%
Market median
+64% vs market
20242025
Return on equity
-103.1%
This company
18.4%
Market median
-660% vs market
20242025
Net profit margin
-6751900.0%
This company
8.1%
Market median
-83356890% vs market
20242025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242025
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20242025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-09 – 2024-10-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PH Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alvolab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Hannes Olauson | Chief Executive Officer | 0 companies |
| Mikhail Burmakin | Deputy Board Member | 0 companies |
| Anna Moa Börjesson | Board of Directors | 0 companies |
| Caroline Linnea Christina Säisä | Board of Directors | 0 companies |
| Tobias Sevek Engström | Board of Directors | 0 companies |
| Denise Wilma Celina Bäverholm | Board of Directors | 0 companies |
| Pär Daniel Roger Johansson | Board of Directors | 0 companies |
| Jens Ove Bäckbom | Chairman | 0 companies |
| Emma Paulina Hallberg | Board of Directors | 0 companies |
| John Simon Jonsson | Chairman | 0 companies |